2Besarab A, Bolton WK, Rrowne JK, et al. The effect of normal as compared with low henmtoerit values in patients with cardiac disease who are receiving hem odialysis and e rythropoictin [ J ]. N Engl J Med,1998,27(9) :584-590.
3Smith KJ, Bleyer AJ, Little WC, et al. The cardiovascular effects of erythropoiet in[ J]. Cardiovascular Research,2003,59 ( 9 ) :538.
二级参考文献19
1Paixao AD, Ferreira AT, Oshiro ME, et al. Renal hemodynamic response to erythropoietin-induced policythemia in 5/6 nephrectomised rats is different from normal rats. Exp Nephrol, 1998,3:245-252.
2Nemoto T, Yokota N, Keane WF, et al. Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure. Kidney Int, 2001,59: 246-251.
3Nushiro N, Sakamaki T, Misawa S, et al. The effects of intrarenal infusion of recombinant human erythropoietin on renal hemodynamics and renal function in anesthesiazed rabbits. Nippon Jinzo Gakhai Shi,1993,35:125-131.
4Jelkmann W. Erythropoietin: Structure, control of production, and function. Physiol Rev,1992,72: 449-489.
5Tan CC, Eckardt KU, Firth JD, et al. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol,1992,263: F474-F481.
6Bernaudin M, Bellail A, Marti HH, et al. Neurons and astrocytes express brain EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia, 2000,30(3): 271-278.
7Westenfelder C. Unexpected renal actions of erythropoietin. Exp Nephrol, 2002,10: 294-298.
8Siren AL, Fratelli M, Brines M, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA, 2001,98:4044-4049.
9Grimm C, Wenzel A, Groszer M, et al. HIF-1-induced erythropoietin in the hypoxic retina protects against light-in-duced retinal degeneration. Nature Med, 2002,8: 718-724.
10Carnot P, DeFlandre C. Sur l'activite hemopoietique de serum au cours de la regeneration du sang. C R Acad Sci (Paris),1906,143:384-386.
7Greaves SC,Gamble GD,Collins JF,et al.Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure[J].Am J Kidney Dis,1994,24(5):768-776.
8Washio M,Okuda S,Mizoue T,et al.Risk factors for left ventricular hypertrophy in chronic hemodialysis patients[J].Clin Nephrol,1997,47(6):362-366.
9Ronald MA,Henry RM,Pite Y,et al.Mild renal insufficiency is associated with increased cardiovascular mortality:the hoorn study[J].Kidney Int,2002,62(4):1402-1407.
10Eschbach JW.Current concepts of anemia management in chronic renal failure:impact of NKF-DOQI[J].Semin Nephrol,2010,20(4):320-329.
